Commentary | Published:

Recombinant antibody microarrays—a viable option?

Nature Biotechnology volume 21, page 223 (2003) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Science 289, 1760–1769 (2000).

  2. 2.

    , & Genome Biol. 2, 0004 (2001).

  3. 3.

    Nat. Genet. 32 (suppl.), 526–532 (2002).

  4. 4.

    & Curr. Opin. Biotechnol. 14, 74–81 (2003).

  5. 5.

    Nat. Biotechnol. 20, 225–229 (2002).

  6. 6.

    Science 294, 2080–2083 (2001).

  7. 7.

    Biotechniques 33 (suppl.), 4–13 (2002).

  8. 8.

    et al. Nat. Biotechnol. 8, 852–856 (2000).

  9. 9.

    , , & Biotechniques 33 (suppl.), 38–45 (2002).

  10. 10.

    & Biotechniques 33 (suppl.), 4–13 (2002).

Download references

Author information

Affiliations

  1. Christer Wingren is a senior scientist in the Department of Immunotechnology, Lund University, SE-220 07 Lund, Sweden

    • Christer Wingren
  2. Johan Ingvarsson is a research associate in the Department of Immunotechnology, Lund University, SE-220 07 Lund, Sweden

    • Johan Ingvarsson
  3. Malin Lindstedt is a research associate in the Department of Immunotechnology, Lund University, SE-220 07 Lund, Sweden

    • Malin Lindstedt
  4. Carl A.K. Borrebaeck is a professor in the Department of Immunotechnology, Lund University, SE-220 07 Lund, Sweden.

    • Carl A.K. Borrebaeck

Authors

  1. Search for Christer Wingren in:

  2. Search for Johan Ingvarsson in:

  3. Search for Malin Lindstedt in:

  4. Search for Carl A.K. Borrebaeck in:

Corresponding author

Correspondence to Carl A.K. Borrebaeck.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0303-223

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing